Fortress Biotech Debt-to-Assets Ratio Growth & History (FBIO)

Fortress Biotech's debt-to-assets ratio was 0.37 for fiscal 2025.

View full Fortress Biotech company overview

Fortress Biotech annual debt-to-assets ratio history

Fortress Biotech annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.37−0.15−28.51%
20242024-12-310.520.03+7.16%
20232023-12-310.490.09+23.94%
20222022-12-310.390.23+136.18%
20212021-12-310.170.10+140.35%
20202020-12-310.07−0.41−85.65%
20192019-12-310.48−0.12−19.32%
20182018-12-310.600.32+117.99%
20172017-12-310.270.10+55.13%
20162016-12-310.18−0.03−12.54%
20152015-12-310.200.05+29.07%
20142014-12-310.16

Fortress Biotech debt-to-assets ratio trends

Over the last five fiscal years, Fortress Biotech's debt-to-assets ratio increased from 0.07 to 0.37, a change of 0.30. The latest reported quarter, Q2 2026, shows 0.15.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Fortress Biotech source filings ↗

Community posts

It’s quiet here.

No posts about FBIO yet. Start the conversation.

Write the first post